Ranjeet Ajmani To Speak at WHIF25
Ranjeet Ajmani, Chief Executive Officer- Asia at Aegros, reposted from World Health Innovation Forum on LinkedIn:
”Self-Reliance in Plasma Products: A Global Imperative
It is both an honor and a privilege to share my thoughts on how India can become self-reliant in the production of plasma-derived medicines (PDMPs), and how this can help many other developing countries improve their plasma collection, regulatory frameworks, and public health policies.
By collaborating on these areas, we can enable countries to either pursue contract fractionation or even set up their own fractionation plants, ensuring they meet the urgent healthcare needs of their populations.
Considering the current geopolitical landscape, this initiative is more critical than ever.
Self-sufficiency in plasma products not only strengthens national healthcare systems but also reduces dependence on international suppliers, mitigating risks tied to global supply chain disruptions.
Now is the time for sharing knowledge, expertise, and learning for the greater good.
After all, patients are patients, and their right to safe, accessible PDMPs should never be questioned.
Together, we can build a future where no one is left behind in the pursuit of better healthcare.”
Quoting World Health Innovation Forum‘s post:
”The visionary shaping Asia’s plasma biopharma landscape!
We are honoured to welcome Dr. Ranjeet Ajmani, Chief Executive Officer – Asia at Aegros, as a speaker at the World Health Innovation Forum (WHIF) 2025.
A pioneer in plasma-derived biopharmaceuticals, Dr. Ajmani has redefined India’s plasma industry, from conceptualizing and executing India’s first contract plasma fractionation model to successfully converting over 100,000 liters of human plasma into Albumin, IVIG, and Factor VIII at highly competitive prices.
His leadership blends strategic vision, operational excellence, and an unwavering commitment to ethical, transparent, and accountable organizational culture.
Join us at WHIF25, hosted by Andhra Pradesh MedTech Zone Limited, to hear from leaders like Dr. Ajmani who are driving innovation, ensuring equitable access, and setting new benchmarks in global healthcare.
December 11–13, 2025
Register now.”
Stay updated with Hemostasis Today.
-
Jan 8, 2026, 05:51Dominika Jędrzejewska Akbaş Links Sleep Deprivation, Obesity, and Stroke
-
Jan 8, 2026, 05:42Rob Maloney: A Bruise that Did Not Go Away…
-
Jan 8, 2026, 05:33Matías J Alet on Treating Early Neurological Deterioration in Lacunar Stroke
-
Jan 8, 2026, 05:11Thomas Meinel Shares The English Stroke Guidelines 2026
-
Jan 8, 2026, 05:03Hilla Ben-Pazi: We Were Pleased to Receive a Grant from the Israeli Ministry of Economy
-
Jan 8, 2026, 04:24Nikhil Agrawal Breaks Down Perioperative Anticoagulation
-
Jan 8, 2026, 03:58Louise St Germain Bannon Appointed Interim Executive Director of ISTH
-
Jan 8, 2026, 03:47Wolfgang Miesbach on Fernando Corrales-Medina’s Team’s Latest Cross-Sectional Study on Haemophilia
-
Jan 8, 2026, 03:28Rick Matthews: Powerful Perspective from Erin and the NBCA Team